Bausch Health (FRA:BVF) Cyclically Adjusted Revenue per Share: €21.01 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:BVF Bausch Health Companies Inc FRA:BVF
60 GF Score
Price €3.90
GF Value €6.13
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Bausch Health Cyclically Adjusted Revenue per Share?

Bausch Health FRA:BVF -3.37% 60 Cyclically Adjusted Revenue per Share is €21.01 as of Mar. 2026. GuruFocus rates FRA:BVF with a GF Score™ of 60/100 and a GF Value™ of €6.13 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bausch Health's adjusted revenue per share for the three months ended in Mar. 2026 was €5.856. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €21.01 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bausch Health's average Cyclically Adjusted Revenue Growth Rate was -1.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.10% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bausch Health was 24.90% per year. The lowest was 2.30% per year. And the median was 11.45% per year.

As of today (2026-07-16), Bausch Health's current stock price is €3.896. Bausch Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €21.01. Bausch Health's Cyclically Adjusted PS Ratio of today is 0.19.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bausch Health was 2.58. The lowest was 0.16. And the median was 0.90.


Bausch Health  (FRA:BVF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bausch Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.896/21.01
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bausch Health was 2.58. The lowest was 0.16. And the median was 0.90.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bausch Health Cyclically Adjusted Revenue per Share Related Terms


Bausch Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Bausch Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health Cyclically Adjusted Revenue per Share Chart

Bausch Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.13 23.85 25.20 23.75 22.79

Bausch Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.30 23.58 22.33 22.79 21.01

FRA:BVF vs ZTS, UTHR: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bausch Health's Cyclically Adjusted PS Ratio falls into.


FRA:BVF
60GF Score
Bausch Health Companies Inc FRA:BVF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bausch Health's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=5.856/132.2623*132.2623
=5.856

Current CPI (Mar. 2026) = 132.2623.

Bausch Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 6.243 102.002 8.095
201609 6.320 101.765 8.214
201612 6.514 101.449 8.493
201703 5.626 102.634 7.250
201706 5.677 103.029 7.288
201709 5.285 103.345 6.764
201712 5.178 103.345 6.627
201803 4.613 105.004 5.811
201806 5.185 105.557 6.497
201809 5.208 105.636 6.521
201812 5.298 105.399 6.648
201903 5.079 106.979 6.279
201906 5.409 107.690 6.643
201909 5.692 107.611 6.996
201912 5.675 107.769 6.965
202003 5.152 107.927 6.314
202006 4.159 108.401 5.074
202009 5.073 108.164 6.203
202012 5.111 108.559 6.227
202103 4.772 110.298 5.722
202106 4.863 111.720 5.757
202109 4.930 112.905 5.775
202112 5.397 113.774 6.274
202203 4.827 117.646 5.427
202206 5.137 120.806 5.624
202209 5.686 120.648 6.233
202212 5.709 120.964 6.242
202303 4.998 122.702 5.387
202306 5.448 124.203 5.801
202309 5.739 125.230 6.061
202312 6.032 125.072 6.379
202403 5.400 126.258 5.657
202406 6.030 127.522 6.254
202409 6.139 127.285 6.379
202412 6.625 127.364 6.880
202503 5.654 129.181 5.789
202506 5.879 129.892 5.986
202509 6.083 130.287 6.175
202512 6.322 130.366 6.414
202603 5.856 132.262 5.856

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €21.01 mean?
Bausch Health (FRA:BVF) has a Cyclically Adjusted Revenue per Share of €21.01 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bausch Health and its competitors.
Is Bausch Health's Cyclically Adjusted Revenue per Share too high?
Bausch Health's current Cyclically Adjusted Revenue per Share is €21.01. Overall, Bausch Health has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Bausch Health's Cyclically Adjusted Revenue per Share of €21.01 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bausch Health and its competitors. Bausch Health's current Cyclically Adjusted Revenue per Share is €21.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Based on GuruFocus' analysis, Bausch Health (FRA:BVF) is currently considered Possible Value Trap. The stock's GF Value™ is €6.13, compared to a current price of €3.90 — trading 36.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €21.01. Bausch Health's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Bausch Health (FRA:BVF), the current Cyclically Adjusted Revenue per Share is €21.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bausch Health (FRA:BVF) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of €3.90 is trading 36.4% below its estimated GF Value™ of €6.13. GuruFocus considers Bausch Health to be Possible Value Trap.

Key valuation signals for FRA:BVF:

  • Cyclically Adjusted Revenue per Share: €21.01
  • GF Value™: €6.13 vs. price of €3.90 (36.4% below fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the FRA:BVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
60GF Score

Get the complete analysis for FRA:BVF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.90
Price
€6.13
GF Value